Get the Stockscreener App
5.65
2.73%
0.15
Serina Therapeutics Inc stock is traded at $5.65, with a volume of 24,872.
It is up +2.73% in the last 24 hours and up +2.54% over the past month.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
See More
Previous Close:
$5.50
Open:
$5.52
24h Volume:
24,872
Relative Volume:
1.36
Market Cap:
$57.92M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.63%
1M Performance:
+2.54%
6M Performance:
+19.45%
1Y Performance:
-30.68%
1-Day Range:
$5.4222
$5.755
1-Week Range:
$5.01
$5.755
52-Week Range:
$3.81
$10.28
Serina Therapeutics Inc Stock (SER) Company Profile
Name
Serina Therapeutics Inc
Sector
Industry
Phone
(256) 327-9630
Address
601 GENOME WAY, HUNTSVILLE
Compare SER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
5.65 | 53.56M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
Serina Therapeutics Inc Stock (SER) Latest News
What MACD and RSI say about Serina Therapeutics Inc.Quarterly Trade Review & Free Accurate Trade Setup Notifications - Newser
Serina Therapeutics Inc. Stock Recovery Path — Analyst BreakdownBear Alert & Safe Entry Momentum Tips - classian.co.kr
Analyzing drawdowns of Serina Therapeutics Inc. with statistical tools2025 Technical Overview & Reliable Breakout Forecasts - Newser
Will Serina Therapeutics Inc. price bounce be sustainableJuly 2025 Sentiment & Entry Point Confirmation Alerts - Newser
Can technical indicators confirm Serina Therapeutics Inc.’s reversalEarnings Risk Summary & Real-Time Volume Analysis Alerts - Newser
How to monitor Serina Therapeutics Inc. with trend dashboardsDay Trade & Community Consensus Stock Picks - Newser
What MACD signals say about Serina Therapeutics Inc.Earnings Recap Report & Consistent Return Strategy Ideas - Newser
Is Serina Therapeutics Inc. stock entering bullish territoryJuly 2025 Fed Impact & Weekly Setup with ROI Potential - Newser
Does Serina Therapeutics Inc. show high probability of reboundProfit Target & Fast Moving Trade Plans - Newser
Real time breakdown of Serina Therapeutics Inc. stock performanceStop Loss & Precise Swing Trade Alerts - Newser
When is the best time to exit Serina Therapeutics Inc.July 2025 Institutional & Technical Buy Zone Confirmation - Newser
Sector ETF performance correlation with Serina Therapeutics Inc.2025 Market Overview & Verified High Yield Trade Plans - Newser
Risk adjusted return profile for Serina Therapeutics Inc. analyzedQuarterly Portfolio Summary & Smart Swing Trading Alerts - Newser
Regression Model Predicts Rangebound Movement in Serina Therapeutics Inc.2025 Biggest Moves & Smart Investment Allocation Tips - beatles.ru
What makes Serina Therapeutics Inc. stock price move sharply2025 Top Decliners & Low Risk High Reward Trade Ideas - newsyoung.net
How sentiment analysis helps forecast Serina Therapeutics Inc.2025 Technical Overview & Accurate Entry and Exit Point Alerts - Newser
Volume spikes in Serina Therapeutics Inc. stock – what they meanMarket Rally & Verified Momentum Stock Watchlist - Newser
Best data tools to analyze Serina Therapeutics Inc. stock2025 Retail Activity & Long-Term Growth Stock Strategies - Newser
Analyzing recovery setups for Serina Therapeutics Inc. investorsJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - Newser
Can Serina Therapeutics Inc. expand into new marketsJuly 2025 Institutional & Free Low Drawdown Momentum Trade Ideas - thegnnews.com
Visualizing Serina Therapeutics Inc. stock with heatmapsJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-08-15 05:16:43 - classian.co.kr
Pet's Best Life Wins “Overall Dog Health Product of the Year” For Longevity15® In 2025 Pet Innovation Awards - GlobeNewswire Inc.
How Serina Therapeutics Inc. stock performs during market volatility [Market Performance Summary]Reliable Momentum Entry Alerts - Newser
Technical Models Suggest Serina Therapeutics Inc. May Rebound SoonTop Gaining Picks With Entry Signals Identified - beatles.ru
Can Serina Therapeutics Inc. recover in the next quarterFree Weekly Setup With 3x Return Potential - Newser
Is Serina Therapeutics Inc. stock a growth or value playStock Market Watch with Smart Filters - Newser
Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire
Serina Therapeutics Pushes Two Novel Drug Programs Forward as Former Karuna CMO Joins Board - Stock Titan
Why Serina Therapeutics Inc. stock attracts strong analyst attentionFree Top Gaining Picks With Entry Signals - Newser
Serina Therapeutics Inc Stock (SER) Financials Data
There is no financial data for Serina Therapeutics Inc (SER). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Serina Therapeutics Inc Stock (SER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Moreadith Randall | Chief Scientific Officer |
Aug 12 '25 |
Sale |
5.25 |
5,500 |
28,875 |
0 |
| Moreadith Randall | Chief Scientific Officer |
Aug 04 '25 |
Option Exercise |
0.06 |
5,500 |
330 |
5,500 |
| Moreadith Randall | Chief Scientific Officer |
Aug 04 '25 |
Sale |
5.17 |
5,500 |
28,435 |
0 |
| Moreadith Randall | Chief Scientific Officer |
Jul 29 '25 |
Option Exercise |
0.06 |
4,196 |
252 |
4,196 |
| Moreadith Randall | Chief Scientific Officer |
Jul 29 '25 |
Sale |
6.50 |
4,196 |
27,274 |
0 |
| Moreadith Randall | Chief Scientific Officer |
Jul 28 '25 |
Option Exercise |
0.06 |
6,500 |
390 |
6,500 |
| Moreadith Randall | Chief Scientific Officer |
Jul 28 '25 |
Sale |
5.89 |
6,500 |
38,285 |
0 |
| Moreadith Randall | Chief Scientific Officer |
Jul 21 '25 |
Option Exercise |
0.06 |
6,500 |
390 |
6,500 |
| Moreadith Randall | Chief Scientific Officer |
Jul 21 '25 |
Sale |
5.34 |
6,500 |
34,710 |
0 |
| Moreadith Randall | Chief Scientific Officer |
Jul 14 '25 |
Option Exercise |
0.06 |
6,500 |
390 |
6,500 |
0.94%
1.72%
Cap:
|
Volume (24h):